Skip to content
Home▶Archive▶Vol. 7 No. 1 (2024)▶Clinical Outcome of Vitamin D Supplementation in Moderate…
Academia Journal of Medicine
Print ISSN 2663-8282 · Online ISSN 2663-8290
Research Paper

Clinical Outcome of Vitamin D Supplementation in Moderate and Severe COVID-19 Patients: A Randomized Clinical Trial

, , , ,
Sanket Agrawal — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Sushant Meshram — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Shruti Agrawal — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Kamlesh Taori — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Shubham Biyani — SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
Published 27 Jun 2024 Vol. 7 No. 1 (2024), pp. 86-89
Formats:PDF 🔒 Subscription
🔒 PDF

Abstract

The COVID-19 pandemic has posed a major global health challenge,  especially for individuals with underlying health issues. This study  aimed to assess the clinical outcomes of vitamin D supplementation in  patients with moderate to severe COVID-19 in a tertiary care hospital  through a randomized clinical trial. Sixty-two SARS-CoV-2 positive  patients were enrolled and divided into intervention (vitamin D  supplementation) and control groups. 

 

KeywordsCOVID-19Vitamin DSupplementationClinical OutcomesRandomized Clinical TrialTertiary Care Hospital
🔒 Full text available to subscribers
  • PDF — print-ready version
  1. 1. World Health Organization. "Coronavirus Disease (COVID-19) Situation Report." 2. Holick, M.F. "Vitamin D deficiency." New England Journal of Medicine, 2007. 3. Grant, W.B., et al. "Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths." Nutrients, 2020.
  2. 4. Dong, E.; Du, H.; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020, 20, 533–534.
  3. 5. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513.
  4. 6. Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.;Wang, H.;Wang, Y.; Zhou, Y.-N. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [PubMed]
  5. 7. Shi, Y.; Yu, X.; Zhao, H.; Wang, H.; Zhao, R.; Sheng, J. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit. Care 2020, 24, 1–4.
  6. 8. Mradul Mohan, Jerin Jose CherianID2, Amit SharmaID1,3 Exploring links between vitamin D deficiency and COVID-19 PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008874 September 18.
  7. 9. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M,Amado JA, Cacho PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol. 2012;91(5):829-838.

Looking up citing articles…